Middle East Respiratory Syndrome
Coronavirus (MERS-CoV) cases identified in United States
As many of
you may be aware through the national news and professional
communications, two cases of the MERS-CoV virus have been
identified in the United States. West Virginia Commissioner of
Health, Letitia Tierney, M.D., has been monitoring this serious
development and has compiled information regarding the situation and
the MERS-CoV virus. Through the following link please find Dr.
Tierney’s communication which provides timely information that
clinicians will need to recognize, treat and report cases.
Click Here for MERS COV Document
FDA Approves first hydrocodone-only
opioid narcotic, Zohydro Extended Release (ER)
11-2 vote against the approval of this drug by the FDA’s own
Anesthetic and Analgesic Drug Advisory Committee, the FDA approved
the use Zohydro ER. This drug was released on the market in March of
this year. Zohydro ER, which lacks abusive deterrent properties, may
contain up to 10 times the hydrocodone found in the heavily abused
combination products such as Vicodin and Lortab. Given that our
state continues to have one of the highest drug overdose mortality
rates in the country, there is great concern over such a potent and
potentially lethal drug being made so readily available. In response
to this serious concern, the Board, with the assistance of the West
Virginia Medical Professionals Health Program and at the suggestion
of West Virginia Attorney General Patrick Morrisey, has compiled
several links, found below, which will aid physicians in
understanding the risks this drug presents, as well as further
information regarding drug itself. It is recommended that great
care be taken in the controlled prescribing and use of this drug.
The Board of
Medicine strongly urges all physicians to become familiar with the
Policy on the Use of Opioid Analgesics in the Treatment of
Chronic Pain in
addition to taking the required course on Best Practice
Prescribing of Controlled Substances and Drug Diversion Training
which can be linked to from our Home Page.
Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules
This is the
manufacturer’s website…content on Zohydro ER….
2. Andrew Kolodny …
recommendation proposal package to DEA by December (last year).
New pain pill's approval: 'Genuinely frightening'
wrote in a letter to FDA
Commissioner Dr. Margaret Hamburg.
The FDA's Dilemma With The Opioid Pain Medication Zohydro ER
surprising about the FDA approval was that the FDA’s Anesthetic and
Analgesic Drug Advisory Committee, made up of independent experts,
had voted against approval of Zohydro ER by an 11 – 2 vote.
FDA Commissioner Margaret Hamburg strongly
defends the agency’s approval, arguing that Zohydro’s benefits
outweigh the negative consequences. Simply put, she says, people in
pain need more options.
New Super Painkiller 'Zohydro,' Out by 2013, is '10 Times Stronger
8. Zogenix Provides Update on
Development of Abuse Deterrent Formulations of Zohydro ER